Common cold viruses may play a role in treating skin cancer, NYU Langone research finds
Source: Becker’s Healthcare, April 2021
A drug combination therapy that pairs a live common cold virus with an immunotherapy drug shrank melanoma tumors in nearly half of patients involved in a small study led by New York City-based NYU Langone Health and its Perlmutter Cancer Center.
